Hypoxia-amplifying polymer nanoprodrugs for sonodynamic chemotherapy for breast cancer and bone metastasis via in situ thrombogenesis

Abstract

Reactive oxygen species (ROS)-producing treatment methods, such as sonodynamic therapy (SDT), usually exhibit limited efficacy for solid tumors because of the hypoxic tumor microenvironment. To address this challenge, we report a hypoxia-amplifying polymer nanoprodrug (DPTT) for breast cancer and bone metastasis therapy via in situ thrombogenesis to improve chemotherapy effects. The nanoprodrug (DPTT) was fabricated via co-loading a sonodynamic semiconducting polymer (SP) and a hypoxia-activated prodrug, tirapazamine (TPZ), into an ROS-responsive nanomicelle decorated with thrombin on the nanoparticle surface. After enrichment at tumor sites, DPTT can produce ROS under ultrasound exposure by the sonodynamic effect of SP for SDT, triggering ROS-responsive structural disintegration and subsequent controlled release of thrombin and TPZ. The liberated thrombin induces fibrin formation and in situ thrombogenesis in tumor tissues, disrupting vascular functions and oxygen supply to further intensify tumor hypoxia. As a consequence, TPZ prodrugs are activated in aggravated hypoxic regions to enable enhanced chemotherapeutic effects. Remarkably, this therapeutic approach is demonstrated to achieve near-complete eradication of subcutaneous 4T1 breast tumors and substantial inhibition of bone metastasis progression in murine models. Our work presents a novel vascular disruption strategy for hypoxia potentiation, offering a promising therapeutic paradigm for treating hypoxic solid and metastatic tumors.

Graphical abstract: Hypoxia-amplifying polymer nanoprodrugs for sonodynamic chemotherapy for breast cancer and bone metastasis via in situ thrombogenesis

Supplementary files

Article information

Article type
Communication
Submitted
25 Jun 2025
Accepted
28 Aug 2025
First published
30 Aug 2025

Mater. Horiz., 2025, Advance Article

Hypoxia-amplifying polymer nanoprodrugs for sonodynamic chemotherapy for breast cancer and bone metastasis via in situ thrombogenesis

J. Ding, X. Wang, F. Wang, W. Pan, J. Li, S. Wang and Y. Han, Mater. Horiz., 2025, Advance Article , DOI: 10.1039/D5MH01208B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements